København, 2013-03-27 14:35 CET (GLOBE NEWSWIRE) -- Vedtægter for ALK-Abelló A/S med seneste ændringer vedtaget på den ordinære generalforsamling den 12. marts 2013.
Recommended Reading
-
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced that the UK’s National Institute for Health and Care Excellence (NICE) has recommended the company’s tree pollen tablet (ITULAZAX®) and house...
Read More -
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) will publish its results for the first six months of 2026 in the morning on Thursday, 20 August 2026. Later on the same day, the company will host a...
Read More